SBFM Q1 2025 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9M+18.0% YoY

Gross Profit

$3M30.7% margin

Operating Income

-$1M-14.6% margin

Net Income

-$1M-13.3% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

-7.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$29M

Total Liabilities

$6M

Stockholders' Equity

$23M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$8M	+18.0%
Gross Profit	$3M	$2M	+18.1%
Operating Income	-$1M	-$1M	+4.1%
Net Income	-$1M	-$1M	+8.1%